VP, DM1 Commercial Asset Lead
Core
Define and execute global commercialization strategy for Dyne's DM1 therapeutic asset to maximize patient access and value creation.
Role type
VP, Commercial Asset Lead (Strategy & Global Launch)
Builds
Global launch plans, competitive positioning, and market access strategies for neuromuscular therapeutics.
Domain
Biopharmaceuticals / Rare Diseases / Neuromuscular Therapeutics
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Global commercial strategy definition, competitive positioning, launch readiness planning, market access and reimbursement strategy, cross-functional program leadership, stakeholder engagement with KOLs and advocacy groups, business development due diligence, strategic imperatives setting, execution prioritization.
Preferred skills
Rare disease commercialization experience, neuromuscular disease domain expertise, experience steering assets from late-stage development through approval.
Technologies
None stated.
Responsibilities
Define global asset commercialization strategy and plan to achieve milestones; Shape competitive positioning and overall value proposition; Lead global launch planning and readiness across key markets starting with the U.S.; Partner with cross-functional teams to prepare for launch execution; Build a credible presence within the DM1 community including KOLs and patient advocacy groups; Participate in business development activities including opportunity evaluation and due diligence.
Seniority
VP, Strategy & Global Execution
